Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Gowling WLG (Canada) LLP

02 12McCarthy Tétrault LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Dulaglutide

Brand Name : TRULICITY

Patent Number : 2528591

Filing Date : 2004-06-10

Strength per Unit : 0.75 mg / 0.5 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2024-06-10

Date Granted : 2013-01-08

blank

02

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Dulaglutide

Brand Name : TRULICITY

Patent Number : 2691695

Filing Date : 2008-07-09

Strength per Unit : 0.75 mg / 0.5 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-07-09

Date Granted : 2014-03-18

blank

03

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Dulaglutide

Brand Name : TRULICITY

Patent Number : 2691695

Filing Date : 2008-07-09

Strength per Unit : 0.75 mg / 0.5 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-07-09

Date Granted : 2014-03-18

blank

04

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Dulaglutide

Brand Name : TRULICITY

Patent Number : 2528591

Filing Date : 2004-06-10

Strength per Unit : 0.75 mg / 0.5 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2024-06-10

Date Granted : 2013-01-08

blank

05

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Dulaglutide

Brand Name : TRULICITY

Patent Number : 2528591

Filing Date : 2004-06-10

Strength per Unit : 1.5 mg / 0.5 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2024-06-10

Date Granted : 2013-01-08

blank

06

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Dulaglutide

Brand Name : TRULICITY

Patent Number : 2691695

Filing Date : 2008-07-09

Strength per Unit : 1.5 mg / 0.5 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-07-09

Date Granted : 2014-03-18

blank

07

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Dulaglutide

Brand Name : TRULICITY

Patent Number : 2528591

Filing Date : 2004-06-10

Strength per Unit : 1.5 mg / 0.5 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2024-06-10

Date Granted : 2013-01-08

blank

08

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Dulaglutide

Brand Name : TRULICITY

Patent Number : 2691695

Filing Date : 2008-07-09

Strength per Unit : 1.5 mg / 0.5 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-07-09

Date Granted : 2014-03-18

blank

09

McCarthy Tétrault LLP

arrow
Peptide Process CMC
Not Confirmed

McCarthy Tétrault LLP

Country
arrow
Peptide Process CMC
Not Confirmed

Dulaglutide

Brand Name : TRULICITY

Patent Number : 3056663

Filing Date : 2019-09-25

Strength per Unit : 0.75 mg / 0.5 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2039-09-25

Date Granted : 2022-10-18

blank

10

McCarthy Tétrault LLP

arrow
Peptide Process CMC
Not Confirmed

McCarthy Tétrault LLP

Country
arrow
Peptide Process CMC
Not Confirmed

Dulaglutide

Brand Name : TRULICITY

Patent Number : 3056663

Filing Date : 2019-09-25

Strength per Unit : 1.5 mg / 0.5 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2039-09-25

Date Granted : 2022-10-18

blank